Paradigm Biopharmaceuticals (ASX:PAR) FFO per Share


ASX:PAR Paradigm Biopharmaceuticals Ltd ASX:PAR
27 GF Score
Price A$0.18
! 4 Warning Signs
View Full Analysis

What is Paradigm Biopharmaceuticals FFO per Share?

FFO per Share only applies to REITs.

ASX:PAR
27GF Score
Paradigm Biopharmaceuticals Ltd ASX:PAR
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paradigm Biopharmaceuticals Business Description

Other Exchanges PBIGF:USAP86:Germany
Address 500 Collins Street, Level 15, Melbourne, VIC, AUS, 3000
Paradigm Biopharmaceuticals Ltd is a late-stage clinical development company engaged in the research and development of therapeutic products for human use in Australia. The firm is engaged in developing injectable pentosan polysulfate sodium (iPPS) for the treatment of pain associated with musculoskeletal disorders driven by injury, inflammation, aging, degenerative disease, infection, or genetic predisposition. The company has registered the trademarks Zilosul and Rhinosul for the commercialization of iPPS.
27GF Score

Get the complete analysis for ASX:PAR

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.18
Price